JNCCN 360 - Immunotherapy - Available Clinical Trials

Advertisement

Advertisement

Available Clinical Trials

Osimertinib With or Without Bevacizumab as Initial Treatment of EGFR-Mutant Lung Cancer

A Phase III, Randomized, Placebo-Controlled Clinical Study of SBRT With or Without Pembrolizumab in Participants With Medically Inoperable NSCLC (KEYNOTE-867)

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study of Multiple Immunotherapy-Based Treatment Combinations in Advanced Liver Cancers

Is Chemotherapy, Bevazicumab, and Atezolizumab Better Than Chemotherapy Alone in Patients With Advanced Liver Cancer?

Atezolizumab in Combination With a Multikinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

A Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

ClinicalTrials.gov Immunotherapy

Center for Immunotherapy Clinical Research Trials

Cancer Research Institute Immunotherapy Clinical Trials

Sections

NCCN Resources

Copyright © 2023 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.